<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="11/04/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=2258623">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>2258623</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Differences in <term sem="DNA_domain_or_region" id="T1" lex="transcriptional_enhancer">transcriptional enhancers</term> of <term sem="Virus" id="T2" lex="HIV-1">HIV-1</term> and <term sem="Virus" id="T3" lex="HIV-2">HIV-2</term>.</sentence>
<sentence id="S2">Response to <term sem="Other" id="T4" lex="T_cell_activation_signals"><term sem="Cell_natural" id="T5" lex="T_cell">T cell</term> activation signals</term>.</sentence>
<event id="E1">
<type class="Regulation" />
<theme idref1="T2" idref="T1" />
<cause idref="T4" />
<clue><clueType>Response</clueType> <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref1="T3" idref="T1" />
<cause idref="T4" />
<clue><clueType>Response</clueType> <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3"><term sem="Other" id="T6" lex="T_cell_activation"><term sem="Cell_natural" id="T7" lex="T_cell">T cell</term> activation</term> results in high levels of <term sem="Other" id="T8" lex="HIV_replication"><term sem="Virus" id="T9" lex="HIV">HIV</term> replication</term> and is thought to be one mechanism leading to the conversion from <cons sem="(TO Other Other)" id="T10" lex="(TO latent_viral_infection active_viral_infection)"><frag id="F1"><term sem="Other" id="A1">latent</term></frag> to <frag id="F2"><term sem="Other" id="A2">active</term></frag> <frag id="F3"><term sem="Other" id="A3">viral infection</term></frag></cons>.</sentence>
<event id="E3">
<type class="Physiological_process" />
<theme idref="T7" />
<clue>T cell <clueType>activation</clueType> results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event id="E4">
<type class="Viral_life_cycle" />
<theme idref="T9" />
<clue>T cell activation results in high levels of HIV <clueType>replication</clueType> and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="E4" />
<clue>T cell activation results in <clueType>high levels</clueType> <linkTheme>of</linkTheme> HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="E29" />
<cause idref="E3" />
<clue>T cell activation <clueType>results</clueType> <linkTheme>in</linkTheme> high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection.</clue>
</event>
<event uncertainty="probable" id="E6">
<type class="Positive_regulation" />
<theme idref1="A3" idref="A1" />
<theme idref1="A3" idref="A2" />
<cause idref="E3" />
<clue>T cell activation results in high levels of HIV replication and is thought to be one mechanism <clueType>leading to the conversion</clueType> <linkTheme>from</linkTheme> latent <linkTheme>to</linkTheme> active viral infection.</clue>
<comment>CAUTION: from A1,A3 to A2,A3</comment>
</event>
<sentence id="S4">In <term sem="Virus" id="T11" lex="HIV-1">HIV-1</term>, the <term sem="DNA_domain_or_region" id="A4">sequences</term> that respond to these <term sem="Other" id="T12" lex="signaling_event">signaling events</term> are found in the <term sem="DNA_domain_or_region" id="T13" lex="long_terminal_repeat">long terminal repeat</term> (<term sem="DNA_domain_or_region" id="T14" lex="LTR">LTR</term>) and comprise the <term sem="DNA_domain_or_region" id="T15" lex="transcriptional_enhancer">transcriptional enhancer</term>, which contains two <term sem="DNA_domain_or_region" id="T16" lex="conserved_binding_sites">conserved binding sites</term> for the <term sem="Protein_molecule" id="T17" lex="nuclear_factor_kappa_B">nuclear factor kappa B</term> (<term sem="Protein_molecule" id="T18" lex="NF_kappa_B">NF kappa B</term>).</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="A4" />
<cause idref="T12" />
<clue><clueLoc>In HIV-1</clueLoc>, the sequences that <clueType>respond</clueType> <linkCause>to</linkCause> these signaling events are found in the long terminal repeat (LTR) and comprise the transcriptional enhancer, which contains two conserved binding sites for the nuclear factor kappa B (NF kappa B).</clue>
</event>
<sentence id="S5">The corresponding region in the <term sem="Virus" id="T19" lex="second_AIDS_retrovirus">second AIDS retrovirus</term>, <term sem="Virus" id="T20" lex="HIV-2">HIV-2</term>, contains a conserved and a divergent <term sem="DNA_domain_or_region" id="T21" lex="NF_kappa_B_binding_site"><term sem="Protein_molecule" id="T22" lex="NF_kappa_B">NF kappa B</term> binding site</term>.</sentence>
<sentence id="S6">We demonstrate that the <term sem="DNA_domain_or_region" id="T23" lex="HIV-1_LTR"><term sem="Virus" id="T24" lex="HIV-1">HIV-1</term> LTR</term> responds better than the <term sem="DNA_domain_or_region" id="T25" lex="HIV-2_LTR"><term sem="Virus" id="T26" lex="HIV-2">HIV-2</term> LTR</term> to <term sem="Other" id="A5">T cell activation signals</term>.</sentence>
<event id="E8">
<type class="Regulation" />
<theme idref="T23" />
<cause idref="A5" />
<clue>We demonstrate that the HIV-1 LTR <clueType>responds</clueType> better than the HIV-2 LTR <linkCause>to</linkCause> T cell activation signals.</clue>
</event>
<event id="E9">
<type class="Regulation" />
<theme idref="T25" />
<cause idref="A5" />
<clue>We demonstrate that the HIV-1 LTR <clueType>responds</clueType> better than the HIV-2 LTR <linkCause>to</linkCause> T cell activation signals.</clue>
<comment>CAUTION: SEE</comment>
</event>
<sentence id="S7">These qualitative differences in the response to <term sem="Other" id="T27" lex="T_cell_activation"><term sem="Cell_natural" id="T28" lex="T_cell">T cell</term> activation</term> are reproduced not only when <cons sem="(OR DNA_domain_or_region DNA_domain_or_region)" id="T29" lex="(OR HIV-1_enhancer HIV-2_enhancer)"><frag id="F4"><term sem="DNA_domain_or_region" id="A6">HIV-1</term></frag> or <frag id="F5"><term sem="DNA_domain_or_region" id="A7">HIV-2</term></frag> <frag id="F6"><term sem="DNA_domain_or_region" id="A8">enhancers</term></frag></cons> are placed upstream of a <term sem="DNA_domain_or_region" id="T30" lex="heterologous_promoter">heterologous promoter</term> but also when these <term sem="DNA_family_or_group" id="T31" lex="enhancer">enhancers</term> are switched between their respective <term sem="DNA_domain_or_region" id="T32" lex="LTR">LTR</term>.</sentence>
<event id="E10">
<type class="Physiological_process" />
<theme idref="T28" />
<clue>These qualitative differences in the response to T cell <clueType>activation</clueType> are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR.</clue>
</event>
<event id="E11">
<type class="Regulation" />
<cause idref="E10" />
<clue>These qualitative differences in the <clueType>response</clueType> <linkCause>to</linkCause> T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when these enhancers are switched between their respective LTR.</clue>
<comment>NO THEME</comment>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E8" />
<cause idref="E27" />
<clue><corefTheme>These qualitative differences</corefTheme> in the response to T cell activation are <clueType>reproduced</clueType> not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also <linkCause>when</linkCause> these enhancers are switched between their respective LTR.</clue>
</event>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="E28" />
<clue><corefTheme>These qualitative differences</corefTheme> in the response to T cell activation are <clueType>reproduced</clueType> not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also <linkCause>when</linkCause> these enhancers are switched between their respective LTR.</clue>
</event>
<event id="E27">
<type class="Mutagenesis" />
<theme idref1="A8" idref="A6" />
<theme idref1="T32" idref="A6" />
<clue>These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when <corefTheme>these enhancers</corefTheme> are <clueType>switched</clueType> <linkTheme>between</linkTheme> their respective LTR.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E28">
<type class="Mutagenesis" />
<theme idref1="A8" idref="A7" />
<theme idref1="T32" idref="A7" />
<clue>These qualitative differences in the response to T cell activation are reproduced not only when HIV-1 or HIV-2 enhancers are placed upstream of a heterologous promoter but also when <corefTheme>these enhancers</corefTheme> are <clueType>switched</clueType> <linkTheme>between</linkTheme> their respective LTR.</clue>
<comment>ARTIFICIAL</comment>
</event>
<sentence id="S8">In electrophoretic mobility shift assays, <term sem="Protein_molecule" id="T33" lex="NF_kappa_B">NF kappa B</term> binds to both <term sem="DNA_domain_or_region" id="A9">conserved sites</term> in the <term sem="DNA_domain_or_region" id="T34" lex="HIV-1_transcriptional_enhancer"><term sem="Virus" id="T35" lex="HIV-1">HIV-1</term> transcriptional enhancer</term> and only to the single <term sem="DNA_domain_or_region" id="A12">conserved site</term> in the <term sem="DNA_domain_or_region" id="T36" lex="HIV-2_transcriptional_enhancer"><term sem="Virus" id="T37" lex="HIV-2">HIV-2</term> transcriptional enhancer</term>.</sentence>
<event id="E14">
<type class="Binding" />
<theme idref="T33" />
<theme idref1="T34" idref="A9" />
<clue><clueExperiment>In electrophoretic mobility shift assays</clueExperiment>, NF kappa B <clueType>binds</clueType> <linkTheme>to</linkTheme> both conserved sites in the HIV-1 transcriptional enhancer and only to the single conserved site in the HIV-2 transcriptional enhancer.</clue>
</event>
<event id="E15">
<type class="Binding" />
<theme idref="T33" />
<theme idref1="T36" idref="A12" />
<clue><clueExperiment>In electrophoretic mobility shift assays</clueExperiment>, NF kappa B <clueType>binds</clueType> to both conserved sites in the HIV-1 transcriptional enhancer and only <linkTheme>to</linkTheme> the single conserved site in the HIV-2 transcriptional enhancer.</clue>
</event>
<sentence id="S9">Instead of <term sem="Protein_molecule" id="T38" lex="NF_kappa_B">NF kappa B</term>, the <term sem="Protein_molecule" id="T39" lex="activator_protein_3">activator protein 3</term> binds to the <term sem="DNA_domain_or_region" id="A11">divergent site</term> in <term sem="Virus" id="T40" lex="HIV-2">HIV-2</term>.</sentence>
<event id="E16">
<type class="Binding" />
<theme idref="T39" />
<theme idref1="T40" idref="A11" />
<clue>Instead of NF kappa B, the activator protein 3 <clueType>binds</clueType> <linkTheme>to</linkTheme> the divergent site in HIV-2.</clue>
</event>
<sentence id="S10">In conclusion, <term sem="Virus" id="T41" lex="HIV-1">HIV-1</term> and <term sem="Virus" id="T42" lex="HIV-2">HIV-2</term> are differentially regulated by <term sem="Other" id="A10"><term sem="Other" id="T43" lex="T_cell_activation">T cell activation</term> signals</term>, and this difference may account for the longer period of <term sem="Other" id="T44" lex="viral_latency">viral latency</term> observed with <term sem="Virus" id="T45" lex="HIV-2">HIV-2</term> than with <term sem="Other" id="T46" lex="HIV-1_infection"><term sem="Virus" id="T47" lex="HIV-1">HIV-1</term> infection</term>.</sentence>
<event id="E17">
<type class="Regulation" />
<theme idref="T41" />
<cause idref="A10" />
<clue>In conclusion, HIV-1 and HIV-2 are differentially <clueType>regulated</clueType> <linkCause>by</linkCause> T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.</clue>
</event>
<event id="E18">
<type class="Regulation" />
<theme idref="T42" />
<cause idref="A10" />
<clue>In conclusion, HIV-1 and HIV-2 are differentially <clueType>regulated</clueType> <linkCause>by</linkCause> T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 infection.</clue>
</event>
<event id="E19">
<type class="Initiation_of_viral_infection" />
<theme idref="T45" />
<clue>In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 <clueType>infection</clueType>.</clue>
</event>
<event id="E20">
<type class="Initiation_of_viral_infection" />
<theme idref="T47" />
<clue>In conclusion, HIV-1 and HIV-2 are differentially regulated by T cell activation signals, and this difference may account for the longer period of viral latency observed with HIV-2 than with HIV-1 <clueType>infection</clueType>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
